If you’re preparing documentation for ANVISA, translation isn’t just another operational step. It’s a critical juncture that can either move your entire process forward or bring it to a halt.
Simple terminology errors or inconsistencies between documents are enough to trigger technical deficiency requests, rework, and approval delays.
What Is Regulatory Translation for ANVISA
Regulatory translation is the technical adaptation of documents used in regulatory processes, ensuring:
• terminological precision
• consistency across documents
• clarity for technical review
Unlike standard translation, the goal isn’t just to convert language — it’s to ensure the content is fully aligned with Brazilian regulatory requirements.
Why Translation Directly Affects Approval
ANVISA doesn’t review documents in isolation.
It checks for:
• coherence across the different files in the dossier
• correct use of technical terminology
• clarity in the description of processes, studies, and products
Any ambiguity raises a question. And in this context, a question becomes a deficiency request.
Key Documents That Require Regulatory Translation
Companies in the pharmaceutical, medical device, and cosmetics sectors regularly deal with:
• drug registration dossiers
• clinical studies
• package inserts and labeling
• medical device manuals (IFU)
• international certificates
• good manufacturing practice documentation
If these documents aren’t aligned with each other, the risk of a deficiency request increases significantly.
The Most Common Translation Mistakes for ANVISA
Literal translation
Technical terms can’t be translated word for word without considering the regulatory context.
Terminology inconsistency
The same term appears translated differently across separate documents.
Lack of standardization
Use of nomenclature that doesn’t follow the standard accepted in Brazil.
No technical review
Translation completed without validation by a subject-matter expert.
The result is predictable:
• deficiency requests
• rework
• approval delays
When You Need Specialized Regulatory Translation
This should be a top priority when:
• you’re registering a product in Brazil
• you’re submitting foreign documentation
• you need to adapt technical content to local requirements
• you’re involved in audits or inspections
If the document has any bearing on regulatory approval, it requires specialized translation.
How to Choose a Regulatory Translation Provider
Look for:
• proven experience in healthcare and regulatory affairs
• familiarity with ANVISA processes
• technical review by subject-matter experts
• terminological quality control
• the ability to handle critical deadlines
If your provider doesn’t talk about regulatory risk, they don’t really understand the problem you’re trying to solve.
What Does Regulatory Translation for ANVISA Cost?
Pricing depends on:
• content complexity
• volume of material
• turnaround time
• need for technical review
But the real cost isn’t in the translation itself.
It’s in the impact a single error can have on your process.
Attach your files and receive a detailed quote for your process within two hours. You’ll be able to track progress in real time and communicate directly with the team about terminology and adjustments.
How to Reduce Risk in Your Regulatory Process
• standardize terminology from the start
• ensure consistency across all documents
• use specialized technical review
• align translation with the regulatory context
Regulatory translation isn’t an operational cost. It’s a lever for efficiency in the approval process.
Why Global Languages Is the Right Choice for Regulatory Translation
In a regulatory context, translating well isn’t enough. You need to understand the impact of every decision on the approval process.
Global Languages works with a clear focus on reducing risk and increasing predictability in regulatory processes, offering:
• consistent terminological standardization throughout the dossier
• technical review aligned with regulatory requirements
• hands-on experience with pharmaceutical and medical device documentation
• quality control that eliminates inconsistencies between documents
In practice, that means fewer deficiency requests, less rework, and greater control over timelines.
While generic providers deliver text, Global Languages works to protect your regulatory process.
Global Languages
BRAZIL
São Paulo: Av. Paulista, 352 – 8th Floor
(11) 3287-3200
UNITED STATES
Miami, FL
1200 Brickell Avenue, Suite 1950
(786) 581-4444
